Ana Navarro Selected Research

Apolipoproteins D (Apo D)

1/2021	Neuroprotective Effect of Apolipoprotein D in Cuprizone-Induced Cell Line Models: A Potential Therapeutic Approach for Multiple Sclerosis and Demyelinating Diseases.
1/2018	Expression Pattern of Myelin-Related Apolipoprotein D in Human Multiple Sclerosis Lesions.
1/2016	Apo J and Apo D: Complementary or Antagonistic Roles in Alzheimer's Disease?
7/2015	Apolipoprotein D subcellular distribution pattern in neuronal cells during oxidative stress.
1/2013	Lifelong expression of apolipoprotein D in the human brainstem: correlation with reduced age-related neurodegeneration.
1/2013	Oxidative stress induces apolipoprotein D overexpression in hippocampus during aging and Alzheimer's disease.
2/2012	Gender differences in apolipoprotein D expression during aging and in Alzheimer disease.
3/2010	Apolipoprotein D synthesis progressively increases in frontal cortex during human lifespan.
1/2008	Apolipoprotein D expression absence in degenerating neurons of human central nervous system.
12/2003	Immunohistochemical study of distribution of apolipoproteins E and D in human cerebral beta amyloid deposits.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ana Navarro Research Topics

Disease

13	Pain (Aches) 04/2022 - 01/2009
11	Neuralgia (Stump Neuralgia) 04/2022 - 01/2009
9	Mitochondrial Diseases (Mitochondrial Disease) 02/2021 - 11/2002
7	Alzheimer Disease (Alzheimer's Disease) 05/2019 - 12/2003
7	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2015 - 01/2008
4	Neoplasms (Cancer) 12/2008 - 03/2003
3	Demyelinating Diseases (Demyelinating Disease) 02/2021 - 01/2018
3	Trigeminal Neuralgia (Tic Douloureux) 01/2011 - 05/2009
2	Multiple Sclerosis 01/2021 - 01/2018
2	Parkinson Disease (Parkinson's Disease) 01/2019 - 06/2009
2	Amyloid Plaque 01/2016 - 12/2003
2	Dementia (Dementias) 06/2013 - 06/2009
2	Traumatic Brain Injuries (Traumatic Brain Injury) 02/2012 - 01/2012
2	Diabetic Neuropathies (Diabetic Neuropathy) 01/2011 - 05/2010
2	Radiculopathy (Radiculopathy, Cervical) 06/2010 - 01/2010
2	Chronic Pain 06/2010 - 05/2010
2	Inflammation (Inflammations) 01/2010 - 11/2002
1	Neuroblastoma 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	Hypokinesia (Bradykinesia) 01/2019
1	Leukemia 01/2018
1	Sclerosis 01/2018
1	Spontaneous Abortion (Miscarriage) 04/2015
1	Congenital Abnormalities (Deformity) 04/2015
1	Allergic Rhinitis 08/2013
1	Memory Disorders (Memory Loss) 06/2013
1	Cognitive Dysfunction 06/2013
1	Peripheral Nervous System Diseases (PNS Diseases) 12/2012
1	Hypersensitivity (Allergy) 09/2012
1	Asthma (Bronchial Asthma) 09/2012
1	Breast Cyst 02/2012
1	Schizophrenia (Dementia Praecox) 02/2011
1	Psychotic Disorders (Schizoaffective Disorder) 02/2011
1	Neoplasm Metastasis (Metastasis) 12/2010
1	Mood Disorders (Mood Disorder) 05/2010
1	Brucellosis (Malta Fever) 01/2010
1	Cholelithiasis 04/2009

Drug/Important Bio-Agent (IBA)

12	Pregabalin (Lyrica)FDA Link 12/2013 - 05/2009
10	Apolipoproteins D (Apo D)IBA 01/2021 - 12/2003
10	Proteins (Proteins, Gene)FDA Link 01/2019 - 11/2002
9	Analgesics (Analgesic Drugs)IBA 06/2013 - 01/2009
4	Prostaglandins BIBA 01/2011 - 05/2009
3	ApolipoproteinsIBA 01/2021 - 12/2003
3	Pharmaceutical PreparationsIBA 04/2015 - 05/2010
3	Gabapentin (Neurontin)FDA LinkGeneric 06/2012 - 07/2010
3	Nitric Oxide Synthase (NO Synthase)IBA 04/2011 - 11/2002
3	Thiobarbituric Acid Reactive SubstancesIBA 06/2009 - 12/2005
2	CuprizoneIBA 02/2021 - 01/2021
2	CytokinesIBA 01/2021 - 11/2002
2	Phospholipids (Phosphatides)FDA LinkGeneric 01/2019 - 10/2008
2	Estrogens (Estrogen)FDA Link 06/2013 - 02/2012
2	AntioxidantsIBA 01/2013 - 02/2011
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 09/2012 - 01/2009
2	Amyloid (Amyloid Fibrils)IBA 01/2012 - 12/2003
2	Vitamin E FDA LinkGeneric 04/2011 - 02/2007
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2010 - 01/2010
2	Superoxide DismutaseIBA 06/2009 - 01/2007
1	Neuroprotective AgentsIBA 01/2021
1	Immunologic Factors (Immunomodulators)IBA 01/2021
1	IronIBA 05/2019
1	metal transporting protein 1 (ferroportin)IBA 05/2019
1	RotenoneIBA 01/2019
1	Glutamic Acid (Glutamate)FDA Link 01/2019
1	malic acid (malate)IBA 01/2019
1	AllergensIBA 08/2013
1	Glycerol (Glycerine)FDA LinkGeneric 08/2013
1	EstersIBA 08/2013
1	Carrier Proteins (Binding Protein)IBA 01/2013
1	ParaffinIBA 01/2013
1	Congo RedIBA 01/2013
1	LipidsIBA 01/2013
1	SolutionsIBA 01/2013
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 06/2012
1	Biomarkers (Surrogate Marker)IBA 02/2011
1	Glutathione (Reduced Glutathione)IBA 02/2011
1	N-Methylaspartate (NMDA)IBA 01/2010
1	Minocycline (Cyclops)FDA LinkGeneric 01/2010
1	Tetracycline (Achromycin)FDA LinkGeneric 01/2010
1	AequorinIBA 01/2010
1	A-factor (Streptomyces)IBA 12/2009
1	Oxygen (Dioxygen)IBA 06/2009
1	Adenosine Triphosphate (ATP)IBA 06/2009
1	Cytochromes aIBA 06/2009
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2009
1	Non-Narcotic Analgesics (Analgesics, Non Narcotic)IBA 01/2009
1	LipocalinsIBA 01/2008
1	IceIBA 07/2007
1	Free RadicalsIBA 02/2007

Therapy/Procedure

6	Therapeutics 06/2013 - 01/2010
3	Radiofrequency Ablation 12/2008 - 03/2003
2	Electrodes (Electrode) 07/2007 - 11/2003
1	Drug Therapy (Chemotherapy) 04/2022
1	Prostatectomy (Retropubic Prostatectomy) 01/2021
1	Laser Therapy (Surgery, Laser) 05/2019
1	Animal Assisted Therapy 01/2018
1	Aftercare (After-Treatment) 06/2012
1	Hepatectomy 12/2010
1	Pain Management 05/2009
1	Laparoscopic Cholecystectomy 04/2009
1	Caloric Restriction 02/2007